Should asymptomatic haemochromatosis be treated? Alternative strategies to appropriate diagnosis need testing.
作者信息
Emery J, Rose P
出版信息
BMJ. 2000 Oct 14;321(7266):955-6.
Abstract
摘要
相似文献
1
2
Strategies for early diagnosis of haemochromatosis.血色素沉着症的早期诊断策略。
Eur J Gastroenterol Hepatol. 2002 Mar;14(3):217-21. doi: 10.1097/00042737-200203000-00003.
3
Screening for hereditary haemochromatosis within families and beyond.家庭内外遗传性血色素沉着症的筛查。
Lancet. 2003 Dec 6;362(9399):1897-8. doi: 10.1016/S0140-6736(03)14963-X.
4
Hereditary haemochromatosis - diagnosis and management.遗传性血色素沉着症——诊断与管理
Aust Fam Physician. 2010 Dec;39(12):938-41.
5
[The prioritisation of genetic screening with primary haemochromatosis as an example].[以原发性血色素沉着症为例的基因筛查优先级]
Ned Tijdschr Geneeskd. 2003 Jul 26;147(30):1442-5.
6
Haemochromatosis and the liver.
J Hepatol. 1999;30 Suppl 1:6-11.
7
Should asymptomatic haemochromatosis be treated? Update from Seamark and Hutchinson.
BMJ. 2000 Oct 14;321(7266):956.
8
The Celtic Curse: Screening Children for Genetic Haemochromatosis.凯尔特人的诅咒：对儿童进行遗传性血色素沉着症筛查
Compr Child Adolesc Nurs. 2024 Jul 29;47(3):146-150. doi: 10.1080/24694193.2024.2375170.
9
Is DNA testing for hemochromatosis diagnosis reliable?
Expert Rev Mol Diagn. 2017 Mar;17(3):203-204. doi: 10.1080/14737159.2017.1283221. Epub 2017 Feb 16.
10
[The prioritization of genetic screening with primary haemochromatosis as an example].[以原发性血色素沉着症为例的基因筛查优先级]
Ned Tijdschr Geneeskd. 2003 Nov 15;147(46):2304-5; author reply 2305.
本文引用的文献
1
Controversy in primary care: Should asymptomatic haemochromatosis be treated?基层医疗中的争议：无症状性血色素沉着症是否应接受治疗？
BMJ. 2000 May 13;320(7245):1314-7. doi: 10.1136/bmj.320.7245.1314.
2
Screening for hereditary haemochromatosis should be implemented now.遗传性血色素沉着症的筛查现在就应该实施。
BMJ. 2000 Jan 15;320(7228):183-4.
3
Gaining informed consent for screening. Is difficult--but many misconceptions need to be undone.获得筛查的知情同意书很难——但许多误解需要消除。
BMJ. 1999 Sep 18;319(7212):722-3. doi: 10.1136/bmj.319.7212.722.
4
Are we really dying for a tan?我们真的会为了晒黑而拼命吗？
BMJ. 1999 Jul 10;319(7202):114-6. doi: 10.1136/bmj.319.7202.114.
5
'Should a mammographic screening programme carry the warning: screening can damage your health!'?乳腺钼靶筛查项目是否应该附上这样的警示：“筛查可能损害您的健康！”
Br J Cancer. 1999 Feb;79(5-6):691-2. doi: 10.1038/sj.bjc.6690111.
6
Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.他莫昔芬预防乳腺癌：国家外科辅助乳腺和肠道项目P-1研究报告。
J Natl Cancer Inst. 1998 Sep 16;90(18):1371-88. doi: 10.1093/jnci/90.18.1371.
7
Hereditary hemochromatosis: gene discovery and its implications for population-based screening.遗传性血色素沉着症：基因发现及其对人群筛查的意义。
JAMA. 1998 Jul 8;280(2):172-8. doi: 10.1001/jama.280.2.172.
Zotero 插件